Conformational altered p53 affects neuronal function: Relevance for the response to toxic insult and growth-associated protein 43 expression

Cell Death and Disease

Volumn 4, Issue 2, 2013, Pages

  Buizza, L ^a   Prandelli, C ^a   Bonini, S A ^a   Delbarba, A ^a   Cenini, G ^a   Lanni, C ^b   Buoso, E ^b   Racchi, M ^b   Govoni, S ^b   Memo, M ^a   Uberti, D ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Alzheimers disease; Oxidative stress; P53; GAP 43; Protein conformation

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MESSENGER RNA; NEUROMODULIN; PROTEIN P53; ROSAPROSTOL; TYROSINE; ZINC CHLORIDE;

ACUTE TOXICITY; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; CLONING; CONTROLLED STUDY; CYTOTOXICITY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICHAEL ADDITION; NERVE CELL; NERVE CELL NECROSIS; NITRATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN TERTIARY STRUCTURE; PROTEIN UNFOLDING; SUPPLEMENTATION; WILD TYPE;

AMYLOID BETA-PROTEIN PRECURSOR; CELL LINE, TUMOR; CELL SURVIVAL; CHLORIDES; GAP-43 PROTEIN; HUMANS; HYDROGEN PEROXIDE; NEURONS; OXIDATIVE STRESS; PROTEIN STRUCTURE, TERTIARY; PROTEIN UNFOLDING; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TYROSINE; ZINC COMPOUNDS;

EID: 84876010649     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.13     Document Type: Article

References (61)

1. Tolstonog GV, Deppert W. Metabolic sensing by p53: keeping the balance between life and death. Proc Natl Acad Sci U S A. 2010; 107: 13193-13194.
2. Brady CA, Attardi LD. p53 at a glance. J Cell Sci 2010; 123: 2527-2532.
3. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331.
4. Kaya SS, Mahmood A, Li Y, Yavuz E, Goksel M, Chopp M. Apoptosis and expression of p53 response proteins and cyclin D1 after cortical impact in rat brain. Brain Res 1999; 818: 23-33.
5. Crumrine RC, Thomas AL, Morgan PF. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J Cereb Blood Flow Metab 1994; 14: 887-891.
6. Hughes PE, Alexi T, Yoshida T, Schreiber SS, Knusel B. Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas showing DNA fragmentation. Neuroscience 1996; 74: 1143-1160.
7. Medrano S, Scrable H. Maintaining appearances-the role of p53 in adult neurogenesis. Biochem Biophys Res Commun 2005; 331: 828-833.
8. Culmsee C, Mattson MP. p53 in neuronal apoptosis. Biochem Biophys Res Commun 2005; 331: 761-777.
9. Hughes PE, Alexi T, Schreiber SS. A role for the tumour suppressor gene p53 in regulating neuronal apoptosis. Neuroreport 1997; 8: v-xii.
10. Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 1996; 16: 1337-1345.
11. Uberti D, Belloni M, Grilli M, Spano P, Memo M. Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids. Eur J Neurosci 1998; 10: 246-254.
12. Li Y, Chopp M, Zhang ZG, Zaloga C, Niewenhuis L, Gautam S. p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke 1994; 25: 849-855; (discussion 55-6).
13. Morrison RS, Kinoshita Y, Johnson MD, Guo W, Garden GA. p53-dependent cell death signaling in neurons. Neurochem Res 2003; 28: 15-27.
14. Culmsee C, Zhu X, Yu QS, Chan SL, Camandola S, Guo Z et al. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J Neurochem 2001; 77: 220-228.
15. Tedeschi A, Nguyen T, Puttagunta R, Gaub P, Di Giovanni SA. p53-CBP/p300 transcription module is required for GAP-43 expression, axon outgrowth, and regeneration. Cell Death Differ 2009; 16: 543-554.
16. Qin Q, Baudry M, Liao G, Noniyev A, Galeano J, Bi X. A novel function for p53: regulation of growth cone motility through interaction with Rho kinase. J. Neurosci 2009; 29: 5183-5192.
17. Denny JB. Molecular mechanisms, biological actions, and neuropharmacology of the growth-associated protein GAP-43. Curr Neuropharmacol 2006; 4: 293-304.
18. Aarts LH, Schotman P, Verhaagen J, Schrama LH, Gispen WH. The role of the neural growth associated protein B-50/GAP-43 in morphogenesis. Adv Exp Med Biol 1998; 446: 85-106.
19. Bendotti C, Baldessari S, Pende M, Southgate T, Guglielmetti F, Samanin R. Relationship between GAP-43 expression in the dentate gyrus and synaptic reorganization of hippocampal mossy fibres in rats treated with kainic acid. Eur J Neurosci 1997; 9: 93-101.
20. Uberti D, Lanni C, Carsana T, Francisconi S, Missale C, Racchi M et al. Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients. Neurobiol Aging 2006; 27: 1193-1201.
21. Lanni C, Racchi M, Stanga S, Mazzini G, Ranzenigo A, Polotti R et al. Unfolded p53 in blood as a predictive signature signature of the transition from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis 2010; 20: 97-104.
22. Lanni C, Racchi M, Mazzini G, Ranzenigo A, Polotti R, Sinforiani E et al. Conformationally altered p53: a novel Alzheimer's disease marker? Mol Psychiatry 2008; 13: 641-647.
23. Serrano J, Fernandez AP, Martinez-Murillo R, Martinez A. High sensitivity to carcinogens in the brain of a mouse model of Alzheimer's disease. Oncogene 2010; 29: 2165-2171.
24. Chetelat G, Villemagne VL, Pike KE, Ellis KA, Ames D, Masters CL et al. Relationship between memory performance and beta-amyloid deposition at different stages of Alzheimer's disease. Neurodegener Dis 2012; 10: 141-144.
25. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008; 14: 837-842.
26. Wu L, Rosa-Neto P, Hsiung GY, Sadovnick AD, Masellis M, Black SE et al. Early-onset familial Alzheimer's disease (EOFAD). Can J Neurol Sci 2012; 39: 436-445.
27. Hartl D, Rohe M, Mao L, Staufenbiel M, Zabel C, Klose J. Impairment of adolescent hippocampal plasticity in a mouse model for Alzheimer's disease precedes disease phenotype. PLoS One 2008; 3: e2759.
28. de la Monte SM, Ng SC, Hsu DW. Aberrant GAP-43 gene expression in Alzheimer's disease. Am J Pathol 1995; 147: 934-946.
29. Coleman PD, Kazee AM, Lapham L, Eskin T, Rogers K. Reduced GAP-43 message levels are associated with increased neurofibrillary tangle density in the frontal association cortex (area 9) in Alzheimer's disease. Neurobiol Aging 1992; 13: 631-639.
30. Tsuzuki K, Fukatsu R, Takamaru Y, Fujii N, Takahata N. Potentially amyloidogenic fragment of 50 kDa and intracellular processing of amyloid precursor protein in cells cultured under leupeptin. Brain Res 1994; 659: 213-220.
31. Multhaup G, Scheuermann S, Schlicksupp A, Simons A, Strauss M, Kemmling A et al. Possible mechanisms of APP-mediated oxidative stress in Alzheimer's disease. Free Radic Biol Med 2002; 33: 45-51.
32. Uchida K. Histidine and lysine as targets of oxidative modification. Amino Acids 2003; 25: 249-257.
33. Sultana R, Butterfield DA. Proteomics identification of carbonylated and HNE-bound brain proteins in Alzheimer's disease. Methods Mol Biol 2009; 566: 123-135.
34. Hainaut P, Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res 1993; 53: 4469-4473.
35. Buizza L, Cenini G, Lanni C, Ferrari-Toninelli G, Prandelli C, Govoni S et al. Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease. PLoS One 2012; 7: e29789.
36. Meplan C, Richard MJ, Hainaut P. Redox signalling and transition metals in the control of the p53 pathway. Biochem Pharmacol 2000; 59: 25-33.
37. Tedeschi A, Di Giovanni S. The non-apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon. EMBO Rep 2009; 10: 576-583.
38. Di Giovanni S, Rathore K. p53-dependent pathways in neurite outgrowth and axonal regeneration. Cell Tissue Res 2012; 349: 87-95.
39. Di Giovanni S, Knights CD, Rao M, Yakovlev A, Beers J, Catania J et al. The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration. EMBO J 2006; 25: 4084-4096.
40. Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M. p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol Cell Biol 1996; 16: 5178-5185.
41. Meplan C, Richard MJ, Hainaut P. Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 2000; 19: 5227-5236.
42. Ondrejcak T, Klyubin I, Hu NW, Barry AE, Cullen WK, Rowan MJ. Alzheimer's disease amyloid beta-protein and synaptic function. Neuromolecular Med 2010; 12: 13-26.
43. Johnston H, Boutin H, Allan SM. Assessing the contribution of inflammation in models of Alzheimer's disease. Biochem Soc Trans 2011; 39: 886-890.
44. Galimberti D, Scarpini E. Inflammation and oxidative damage in Alzheimer's disease: friend or foe? Front Biosci (Schol Ed) 2011; 3: 252-266.
45. Sultana R, Butterfield DA. Role of oxidative stress in the progression of Alzheimer's disease. J Alzheimers Dis 2010; 19: 341-353.
46. Cai Z, Zhao B, Ratka A. Oxidative stress and beta-amyloid protein in Alzheimer's disease. Neuromolecular Med 2011; 13: 223-250.
47. Uberti D, Cenini G, Olivari L, Ferrari-Toninelli G, Porrello E, Cecchi C et al. Over-expression of amyloid precursor protein in HEK cells alters p53 conformational state and protects against doxorubicin. J Neurochem 2007; 103: 322-333.
48. Cenini G, Maccarinelli G, Lanni C, Bonini SA, Ferrari-Toninelli G, Govoni S et al. Wild type but not mutant APP is involved in protective adaptive responses against oxidants. Amino Acids 2010; 39: 271-283.
49. Lanni C, Uberti D, Racchi M, Govoni S, Memo M. Unfolded p53: a potential biomarker for Alzheimer's disease. J Alzheimers Dis 2007; 12: 93-99.
50. Velu CS, Niture SK, Doneanu CE, Pattabiraman N, Srivenugopal KS. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-Binding domain during oxidative stress. Biochemistry 2007; 46: 7765-7780.
51. Calmels S, Hainaut P, Ohshima H. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res 1997; 57: 3365-3369.
52. Willis A, Jung EJ, Wakefield T, Chen X. Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes. Oncogene 2004; 23: 2330-2338.
53. Tsvetkov P, Reuven N, Shaul Y. Ubiquitin-independent p53 proteasomal degradation. Cell Death Differ 2010; 17: 103-108.
54. Cregan SP, MacLaurin JG, Craig CG, Robertson GS, Nicholson DW, Park DS et al. Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons. J Neurosci 1999; 19: 7860-7869.
55. Xu X, Yang D, Wyss-Coray T, Yan J, Gan L, Sun Y et al. Wild-type but not Alzheimermutant amyloid precursor protein confers resistance against p53-mediated apoptosis. Proc Natl Acad Sci U S A. 1999; 96: 7547-7552.
56. Lanni C, Racchi M, Memo M, Govoni S, Uberti D. p53 at the crossroads between cancer and neurodegeneration. Free Radic Biol Med 2012; 52: 1727-1733.
57. Sun XZ, Vinci C, Makmura L, Han SB, Tran D, Nguyen J et al. Formation of disulfide bond in p53 correlates with inhibition of DNA binding and tetramerization. Antioxid Redox Sign 2003; 5: 655-665.
58. Drake J, Sultana R, Aksenova M, Calabrese V, Butterfield DA. Elevation of mitochondrial glutathione by gamma-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress. J Neurosci Res 2003; 74: 917-927.
59. Lauderback CM, Hackett JM, Huang FF, Keller JN, Szweda LI, Markesbery WR et al. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J Neurochem 2001; 78: 413-416.
60. Rozen SL, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds) Bioinformatics Methods and Protocols: Methods in Molecular Biology. Humana Press: Totowa, NJ, 2000, pp 365-386.
61. Lanni C, Nardinocchi L, Puca R, Stanga S, Uberti D, Memo M et al. Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival. PLoS One 2010; 5: e10171.